Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hes1
|
ENSMUSG00000022528.7 | hes family bHLH transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr16_30057047_30057229 | Hes1 | 7246 | 0.156055 | 0.52 | 5.7e-05 | Click! |
chr16_30052415_30052574 | Hes1 | 11890 | 0.144507 | -0.47 | 3.4e-04 | Click! |
chr16_30059096_30059771 | Hes1 | 4951 | 0.169460 | 0.43 | 1.2e-03 | Click! |
chr16_30066124_30067475 | Hes1 | 461 | 0.777327 | 0.34 | 1.2e-02 | Click! |
chr16_30063252_30064537 | Hes1 | 490 | 0.758666 | 0.33 | 1.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_61225302_61226760 | 5.79 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr18_12947284_12947832 | 4.86 |
Osbpl1a |
oxysterol binding protein-like 1A |
5717 |
0.19 |
chr9_40268412_40269319 | 4.15 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
352 |
0.82 |
chr1_38835547_38836894 | 4.00 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr4_57567702_57568390 | 3.98 |
Pakap |
paralemmin A kinase anchor protein |
113 |
0.98 |
chr7_19118025_19118835 | 3.70 |
Gm4969 |
predicted gene 4969 |
62 |
0.92 |
chr15_51828888_51829155 | 3.57 |
Eif3h |
eukaryotic translation initiation factor 3, subunit H |
7236 |
0.22 |
chr13_51594988_51595203 | 3.50 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
25608 |
0.16 |
chr13_83727309_83727854 | 3.44 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
525 |
0.66 |
chr9_86879639_86880662 | 3.40 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr13_49370675_49371884 | 3.39 |
Bicd2 |
BICD cargo adaptor 2 |
11810 |
0.19 |
chr19_31663877_31664085 | 3.31 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
389 |
0.92 |
chr10_49788379_49788942 | 3.29 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
94 |
0.6 |
chr5_38158989_38159808 | 3.22 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr1_3671269_3672324 | 3.03 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr3_73056881_73057482 | 3.03 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr8_22059822_22060403 | 2.96 |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
93 |
0.89 |
chr7_80900915_80901390 | 2.95 |
Wdr73 |
WD repeat domain 73 |
67 |
0.95 |
chr17_13759899_13761731 | 2.92 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr5_122950982_122952145 | 2.81 |
Kdm2b |
lysine (K)-specific demethylase 2B |
427 |
0.77 |
chr13_119755130_119755547 | 2.75 |
Nim1k |
NIM1 serine/threonine protein kinase |
544 |
0.49 |
chr8_4492910_4494136 | 2.75 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr13_97071173_97072309 | 2.74 |
Fam169a |
family with sequence similarity 169, member A |
98 |
0.96 |
chr14_61172444_61173564 | 2.69 |
Sacs |
sacsin |
14 |
0.98 |
chr13_12105853_12107098 | 2.68 |
Ryr2 |
ryanodine receptor 2, cardiac |
16 |
0.98 |
chr7_114116927_114117657 | 2.65 |
Rras2 |
related RAS viral (r-ras) oncogene 2 |
472 |
0.85 |
chr1_166308870_166309730 | 2.65 |
5330438I03Rik |
RIKEN cDNA 5330438I03 gene |
285 |
0.91 |
chr2_24761902_24762681 | 2.63 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
756 |
0.65 |
chr11_33843303_33843965 | 2.62 |
Kcnip1 |
Kv channel-interacting protein 1 |
49 |
0.99 |
chr11_79590966_79591301 | 2.62 |
Rab11fip4 |
RAB11 family interacting protein 4 (class II) |
79 |
0.95 |
chr13_110394850_110395480 | 2.60 |
Plk2 |
polo like kinase 2 |
117 |
0.97 |
chr3_116251584_116252494 | 2.60 |
Gpr88 |
G-protein coupled receptor 88 |
1050 |
0.53 |
chr13_104517962_104518622 | 2.60 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
166639 |
0.03 |
chr4_116016940_116018214 | 2.59 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr6_129533069_129533908 | 2.58 |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
63 |
0.68 |
chr13_51170738_51171698 | 2.58 |
Nxnl2 |
nucleoredoxin-like 2 |
159 |
0.95 |
chr5_26817616_26817767 | 2.52 |
Dpp6 |
dipeptidylpeptidase 6 |
257 |
0.93 |
chr1_155233440_155234889 | 2.51 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr2_90885655_90886093 | 2.49 |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
14 |
0.95 |
chr3_32616403_32617072 | 2.47 |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
152 |
0.95 |
chr2_178142310_178142985 | 2.46 |
Phactr3 |
phosphatase and actin regulator 3 |
714 |
0.75 |
chr8_71469378_71469964 | 2.44 |
Dda1 |
DET1 and DDB1 associated 1 |
386 |
0.69 |
chr2_151970289_151970825 | 2.44 |
Fam110a |
family with sequence similarity 110, member A |
2837 |
0.17 |
chr4_141011762_141012413 | 2.43 |
Mfap2 |
microfibrillar-associated protein 2 |
1443 |
0.27 |
chr2_151701768_151703133 | 2.41 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr8_125569269_125570645 | 2.40 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr9_83806172_83806700 | 2.40 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
159 |
0.96 |
chr11_6603325_6604219 | 2.38 |
Nacad |
NAC alpha domain containing |
2281 |
0.14 |
chr16_17802923_17803436 | 2.38 |
Scarf2 |
scavenger receptor class F, member 2 |
223 |
0.86 |
chr19_32755763_32756646 | 2.34 |
Pten |
phosphatase and tensin homolog |
1293 |
0.51 |
chr3_62603661_62604074 | 2.34 |
Gpr149 |
G protein-coupled receptor 149 |
1093 |
0.65 |
chr7_24883912_24885132 | 2.34 |
Rps19 |
ribosomal protein S19 |
111 |
0.92 |
chr12_21136010_21136733 | 2.31 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
24417 |
0.18 |
chr7_44441934_44442325 | 2.31 |
Lrrc4b |
leucine rich repeat containing 4B |
356 |
0.7 |
chr9_110245036_110245402 | 2.30 |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
264 |
0.87 |
chr8_36457363_36458468 | 2.28 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chrX_158043199_158043626 | 2.28 |
Cnksr2 |
connector enhancer of kinase suppressor of Ras 2 |
118 |
0.98 |
chr6_42709318_42710223 | 2.26 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
301 |
0.81 |
chr3_31309752_31310443 | 2.25 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
281 |
0.81 |
chr4_33524476_33525134 | 2.23 |
Gm11935 |
predicted gene 11935 |
71916 |
0.1 |
chr5_140542913_140543170 | 2.23 |
Gm42808 |
predicted gene 42808 |
3351 |
0.16 |
chr6_145866615_145866856 | 2.22 |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
1177 |
0.44 |
chr6_103512188_103512529 | 2.22 |
Chl1 |
cell adhesion molecule L1-like |
1028 |
0.51 |
chr8_84990346_84991110 | 2.21 |
Hook2 |
hook microtubule tethering protein 2 |
86 |
0.9 |
chr18_58209485_58209864 | 2.20 |
Fbn2 |
fibrillin 2 |
252 |
0.95 |
chr17_87613445_87613883 | 2.19 |
Epcam |
epithelial cell adhesion molecule |
22315 |
0.16 |
chr2_102451171_102452295 | 2.19 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr5_25222715_25223033 | 2.17 |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
8 |
0.8 |
chr16_42275501_42275854 | 2.14 |
Gap43 |
growth associated protein 43 |
395 |
0.88 |
chr16_31932750_31933099 | 2.14 |
Gm49731 |
predicted gene, 49731 |
723 |
0.36 |
chr16_38742372_38743125 | 2.14 |
B4galt4 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4 |
427 |
0.78 |
chr8_17534538_17535388 | 2.12 |
Csmd1 |
CUB and Sushi multiple domains 1 |
318 |
0.95 |
chr12_55599599_55600501 | 2.11 |
Insm2 |
insulinoma-associated 2 |
623 |
0.71 |
chr14_3948585_3949537 | 2.10 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr19_28834751_28835188 | 2.08 |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
80 |
0.97 |
chr1_42229794_42229982 | 2.08 |
Gm9915 |
predicted gene 9915 |
161 |
0.95 |
chr4_155694691_155694886 | 2.07 |
Fndc10 |
fibronectin type III domain containing 10 |
446 |
0.63 |
chr13_99397251_99397560 | 2.05 |
6430562O15Rik |
RIKEN cDNA 6430562O15 gene |
15216 |
0.18 |
chr2_149830360_149831343 | 2.05 |
Syndig1 |
synapse differentiation inducing 1 |
8 |
0.86 |
chr3_88205532_88206477 | 2.04 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr2_127521161_127522051 | 2.04 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr12_112949687_112950749 | 2.04 |
Gm26583 |
predicted gene, 26583 |
294 |
0.79 |
chr8_71374903_71376449 | 2.02 |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
114 |
0.92 |
chr12_30372910_30373696 | 2.02 |
Sntg2 |
syntrophin, gamma 2 |
8 |
0.98 |
chr1_93210132_93210761 | 2.01 |
Sned1 |
sushi, nidogen and EGF-like domains 1 |
25395 |
0.11 |
chr12_34907199_34907521 | 2.00 |
Hdac9 |
histone deacetylase 9 |
303 |
0.9 |
chr16_45724098_45724715 | 2.00 |
Tagln3 |
transgelin 3 |
202 |
0.92 |
chr2_113828734_113829247 | 1.99 |
Scg5 |
secretogranin V |
131 |
0.96 |
chr14_60176584_60177406 | 1.99 |
Atp8a2 |
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
544 |
0.71 |
chr7_4120579_4121016 | 1.98 |
9430041J12Rik |
RIKEN cDNA 9430041J12 gene |
69 |
0.88 |
chr3_108085301_108086522 | 1.96 |
Gm12500 |
predicted gene 12500 |
65 |
0.8 |
chr15_95880469_95881076 | 1.93 |
Gm25070 |
predicted gene, 25070 |
955 |
0.57 |
chr2_17730264_17731671 | 1.93 |
Nebl |
nebulette |
76 |
0.98 |
chr6_126739935_126740139 | 1.92 |
Kcna6 |
potassium voltage-gated channel, shaker-related, subfamily, member 6 |
114 |
0.96 |
chr13_43711754_43711916 | 1.92 |
Gm20751 |
predicted gene, 20751 |
4956 |
0.22 |
chr8_3587275_3588562 | 1.92 |
Camsap3 |
calmodulin regulated spectrin-associated protein family, member 3 |
106 |
0.92 |
chr13_14522874_14523297 | 1.91 |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
20 |
0.92 |
chr8_46210360_46210863 | 1.90 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
419 |
0.73 |
chr8_75033246_75033726 | 1.89 |
Tom1 |
target of myb1 trafficking protein |
219 |
0.71 |
chr8_75212715_75213244 | 1.89 |
Rasd2 |
RASD family, member 2 |
965 |
0.51 |
chr16_20589916_20590682 | 1.89 |
Vwa5b2 |
von Willebrand factor A domain containing 5B2 |
86 |
0.78 |
chrX_100767870_100768490 | 1.88 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
185 |
0.93 |
chr2_22622362_22622693 | 1.88 |
Gad2 |
glutamic acid decarboxylase 2 |
322 |
0.84 |
chr12_102948773_102949716 | 1.86 |
Unc79 |
unc-79 homolog |
310 |
0.88 |
chr1_36785255_36785659 | 1.86 |
Zap70 |
zeta-chain (TCR) associated protein kinase |
6473 |
0.13 |
chr10_3366272_3367238 | 1.85 |
Ppp1r14c |
protein phosphatase 1, regulatory inhibitor subunit 14C |
211 |
0.95 |
chr12_26414308_26415459 | 1.85 |
Mir6538 |
microRNA 6538 |
127 |
0.66 |
chr15_25413344_25413753 | 1.85 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
150 |
0.85 |
chr12_31074463_31075268 | 1.85 |
Fam110c |
family with sequence similarity 110, member C |
1004 |
0.43 |
chr6_32520283_32520435 | 1.85 |
Plxna4os1 |
plexin A4, opposite strand 1 |
9286 |
0.24 |
chr12_71640072_71640288 | 1.84 |
9630002D21Rik |
RIKEN cDNA 9630002D21 gene |
62215 |
0.12 |
chr5_33689415_33689612 | 1.84 |
Gm42965 |
predicted gene 42965 |
6539 |
0.11 |
chr17_17829433_17829647 | 1.84 |
Mir99b |
microRNA 99b |
648 |
0.29 |
chr3_156560833_156561074 | 1.82 |
4930570G19Rik |
RIKEN cDNA 4930570G19 gene |
629 |
0.54 |
chr7_64539337_64539734 | 1.82 |
Gm44721 |
predicted gene 44721 |
10110 |
0.19 |
chr12_55473565_55474273 | 1.82 |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
17891 |
0.16 |
chrX_6172599_6172815 | 1.82 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
308 |
0.91 |
chr4_115133632_115134181 | 1.82 |
Cyp4x1 |
cytochrome P450, family 4, subfamily x, polypeptide 1 |
71 |
0.49 |
chr5_125267620_125268072 | 1.81 |
Gm32585 |
predicted gene, 32585 |
4969 |
0.19 |
chr8_4212633_4214018 | 1.81 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr15_13173508_13173824 | 1.81 |
Cdh6 |
cadherin 6 |
9 |
0.99 |
chr3_104638107_104638485 | 1.79 |
Slc16a1 |
solute carrier family 16 (monocarboxylic acid transporters), member 1 |
372 |
0.74 |
chr7_79499656_79500079 | 1.79 |
Mir9-3hg |
Mir9-3 host gene |
159 |
0.9 |
chr18_23310224_23310683 | 1.78 |
Gm7788 |
predicted gene 7788 |
93784 |
0.08 |
chr2_163839584_163839735 | 1.78 |
Kcnk15 |
potassium channel, subfamily K, member 15 |
13992 |
0.17 |
chr9_92174418_92174607 | 1.78 |
Plscr5 |
phospholipid scramblase family, member 5 |
18424 |
0.21 |
chr10_29143863_29144732 | 1.78 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr11_60046440_60046768 | 1.77 |
Pemt |
phosphatidylethanolamine N-methyltransferase |
115 |
0.96 |
chr2_152056466_152056680 | 1.77 |
AA387200 |
expressed sequence AA387200 |
20235 |
0.13 |
chr16_46009777_46011157 | 1.76 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
249 |
0.91 |
chr9_41697271_41698297 | 1.76 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr10_80302176_80302965 | 1.76 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
750 |
0.36 |
chr4_25799474_25800254 | 1.76 |
Fut9 |
fucosyltransferase 9 |
9 |
0.98 |
chr5_106926127_106926590 | 1.76 |
Hfm1 |
HFM1, ATP-dependent DNA helicase homolog |
37 |
0.97 |
chr18_65697684_65698354 | 1.76 |
Oacyl |
O-acyltransferase like |
249 |
0.9 |
chr13_12650037_12651101 | 1.76 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr4_59783359_59783713 | 1.75 |
Inip |
INTS3 and NABP interacting protein |
272 |
0.91 |
chr16_92200759_92201082 | 1.75 |
Gm29880 |
predicted gene, 29880 |
6568 |
0.15 |
chr7_87584064_87584461 | 1.75 |
Grm5 |
glutamate receptor, metabotropic 5 |
94 |
0.98 |
chr7_57591199_57591501 | 1.75 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
177 |
0.96 |
chr8_40634456_40635069 | 1.75 |
Mtmr7 |
myotubularin related protein 7 |
3 |
0.98 |
chr14_123626303_123627238 | 1.75 |
Nalcn |
sodium leak channel, non-selective |
106 |
0.98 |
chr2_35775823_35776075 | 1.73 |
Gm43760 |
predicted gene 43760 |
10070 |
0.2 |
chr11_6065587_6066320 | 1.73 |
Camk2b |
calcium/calmodulin-dependent protein kinase II, beta |
205 |
0.94 |
chr10_78464271_78465733 | 1.73 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr4_73790618_73791250 | 1.73 |
Rasef |
RAS and EF hand domain containing |
60 |
0.8 |
chr13_54309432_54309638 | 1.72 |
Gm48623 |
predicted gene, 48623 |
6977 |
0.17 |
chr7_105580903_105581664 | 1.72 |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 |
5 |
0.95 |
chr4_119931992_119932143 | 1.71 |
Hivep3 |
human immunodeficiency virus type I enhancer binding protein 3 |
100699 |
0.07 |
chr13_80962745_80963559 | 1.71 |
9330111N05Rik |
RIKEN cDNA 9330111N05 gene |
264 |
0.71 |
chr3_105538840_105539458 | 1.70 |
Gm43847 |
predicted gene 43847 |
36242 |
0.16 |
chr13_13393240_13394314 | 1.70 |
Gpr137b |
G protein-coupled receptor 137B |
153 |
0.93 |
chr9_10904618_10904989 | 1.70 |
Cntn5 |
contactin 5 |
28 |
0.89 |
chr3_141936600_141936978 | 1.70 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
5266 |
0.33 |
chr2_18799480_18799858 | 1.69 |
Carlr |
cardiac and apoptosis-related long non-coding RNA |
2149 |
0.3 |
chr14_24827598_24827976 | 1.69 |
Gm47906 |
predicted gene, 47906 |
5848 |
0.28 |
chr5_5663490_5664099 | 1.68 |
Cfap69 |
cilia and flagella associated protein 69 |
249 |
0.91 |
chr9_62536098_62537614 | 1.68 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr17_55445850_55446443 | 1.68 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
98 |
0.98 |
chr3_89233602_89234072 | 1.68 |
Muc1 |
mucin 1, transmembrane |
2366 |
0.09 |
chr1_180791165_180791465 | 1.68 |
H3f3a |
H3.3 histone A |
22219 |
0.09 |
chr15_86185704_86186416 | 1.68 |
Cerk |
ceramide kinase |
81 |
0.8 |
chr11_101465601_101466398 | 1.67 |
Vat1 |
vesicle amine transport 1 |
231 |
0.67 |
chr19_10869236_10869907 | 1.67 |
Tmem132a |
transmembrane protein 132A |
207 |
0.88 |
chr4_44664313_44664465 | 1.67 |
Gm12462 |
predicted gene 12462 |
26 |
0.97 |
chr12_86887931_86888776 | 1.66 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
3555 |
0.23 |
chr13_96130906_96131482 | 1.66 |
Sv2c |
synaptic vesicle glycoprotein 2c |
1383 |
0.35 |
chr5_36868372_36868572 | 1.66 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
41 |
0.97 |
chrX_140665508_140665733 | 1.66 |
Mid2 |
midline 2 |
548 |
0.75 |
chr18_43393020_43393658 | 1.66 |
Dpysl3 |
dihydropyrimidinase-like 3 |
38 |
0.98 |
chr2_94273064_94274137 | 1.66 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr12_112721309_112722969 | 1.65 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr11_120721167_120722110 | 1.65 |
Rac3 |
Rac family small GTPase 3 |
65 |
0.91 |
chr5_52116033_52116570 | 1.65 |
Gm43177 |
predicted gene 43177 |
1011 |
0.45 |
chr2_181155784_181156149 | 1.64 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
1048 |
0.37 |
chr18_9213460_9213964 | 1.64 |
Fzd8 |
frizzled class receptor 8 |
1549 |
0.47 |
chr1_171380284_171380616 | 1.64 |
Arhgap30 |
Rho GTPase activating protein 30 |
8504 |
0.07 |
chr8_14381522_14381725 | 1.64 |
Dlgap2 |
DLG associated protein 2 |
111 |
0.98 |
chr11_69088145_69088599 | 1.64 |
Vamp2 |
vesicle-associated membrane protein 2 |
118 |
0.89 |
chr12_103324974_103325864 | 1.64 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
10165 |
0.11 |
chr9_57504221_57504602 | 1.64 |
Rpp25 |
ribonuclease P/MRP 25 subunit |
385 |
0.72 |
chr7_82335302_82335966 | 1.63 |
Adamtsl3 |
ADAMTS-like 3 |
60 |
0.98 |
chr3_8509423_8509607 | 1.63 |
Stmn2 |
stathmin-like 2 |
0 |
0.98 |
chrX_147553490_147553902 | 1.63 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
354 |
0.91 |
chr3_33844210_33844405 | 1.63 |
Ccdc39 |
coiled-coil domain containing 39 |
3 |
0.97 |
chr3_156562087_156562452 | 1.63 |
Negr1 |
neuronal growth regulator 1 |
119 |
0.87 |
chr12_29723997_29724347 | 1.62 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
37727 |
0.21 |
chr10_118102987_118104071 | 1.62 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
chr15_78835129_78836581 | 1.61 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
6769 |
0.09 |
chr8_87960765_87960916 | 1.61 |
Zfp423 |
zinc finger protein 423 |
1245 |
0.57 |
chr16_33605736_33606716 | 1.61 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr1_169968566_169969463 | 1.61 |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
227 |
0.67 |
chr5_37289066_37289316 | 1.60 |
Crmp1 |
collapsin response mediator protein 1 |
5292 |
0.18 |
chr3_55242068_55243398 | 1.60 |
Dclk1 |
doublecortin-like kinase 1 |
207 |
0.94 |
chr6_122485766_122486276 | 1.60 |
Rimklb |
ribosomal modification protein rimK-like family member B |
418 |
0.77 |
chr5_37245453_37245604 | 1.60 |
Crmp1 |
collapsin response mediator protein 1 |
236 |
0.93 |
chr12_111758304_111760062 | 1.60 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr12_70346175_70346671 | 1.60 |
Trim9 |
tripartite motif-containing 9 |
666 |
0.55 |
chr13_13783865_13785053 | 1.59 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
130 |
0.96 |
chr13_63336316_63336929 | 1.59 |
Gm16133 |
predicted gene 16133 |
3412 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.4 | 5.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.3 | 4.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.3 | 4.0 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 3.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.2 | 3.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.1 | 4.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.1 | 1.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.1 | 2.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.0 | 4.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 1.0 | GO:0086029 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.9 | 4.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.9 | 1.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.9 | 0.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.9 | 2.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.9 | 1.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.9 | 2.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 2.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.8 | 4.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.8 | 3.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.8 | 1.6 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.8 | 3.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.8 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 1.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.8 | 2.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.8 | 0.8 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.8 | 5.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.8 | 2.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.7 | 4.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.7 | 0.7 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 2.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.7 | 2.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.7 | 2.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.7 | 2.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.7 | 2.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.7 | 0.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.7 | 7.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.7 | 2.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.7 | 3.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.7 | 0.7 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.7 | 2.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.7 | 2.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.7 | 2.6 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.7 | 1.3 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.7 | 2.0 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.6 | 0.6 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 7.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 0.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.6 | 1.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.6 | 2.6 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 0.6 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.6 | 3.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.6 | 2.5 | GO:0046959 | habituation(GO:0046959) |
0.6 | 1.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.6 | 2.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 1.9 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 1.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.6 | 12.9 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.6 | 0.6 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.6 | 1.2 | GO:0046958 | nonassociative learning(GO:0046958) |
0.6 | 1.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.6 | 3.5 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.6 | 0.6 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.6 | 2.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.6 | 1.1 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.6 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 2.3 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.6 | 2.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.5 | 1.6 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.5 | 2.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 1.6 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.5 | 6.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 2.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 2.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 0.5 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 3.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.5 | 1.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.5 | 1.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.5 | 2.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.5 | 3.6 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.5 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 2.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 4.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.5 | 3.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 1.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.5 | 2.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 1.5 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.5 | 4.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.5 | 1.5 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 2.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 2.0 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 1.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 1.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 1.5 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.5 | 4.4 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 1.9 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 1.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.5 | 4.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.5 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 1.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 0.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.5 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.5 | 8.9 | GO:0001964 | startle response(GO:0001964) |
0.5 | 2.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 0.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.5 | 2.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.5 | 1.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.5 | 1.4 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 3.7 | GO:0001975 | response to amphetamine(GO:0001975) |
0.5 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 3.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 0.5 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.5 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 3.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.4 | 4.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.4 | 7.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 0.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.4 | 0.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 2.2 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.4 | 6.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 4.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 2.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 3.4 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.4 | 0.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 0.4 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.4 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 2.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.4 | 1.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.4 | 0.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 0.8 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.4 | 1.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 0.8 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 0.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 2.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 1.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 1.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 1.6 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.4 | 1.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 6.6 | GO:0035640 | exploration behavior(GO:0035640) |
0.4 | 1.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 1.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 1.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 1.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.4 | 0.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 2.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.4 | 3.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 3.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 1.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 1.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 1.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 0.7 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 1.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.4 | 1.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.4 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 1.1 | GO:0045297 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.4 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 2.5 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.4 | 1.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.4 | 1.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 1.4 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.4 | 0.7 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.4 | 1.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 1.4 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.3 | 1.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.3 | 1.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 1.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.3 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 2.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 2.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 0.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 2.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 9.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 1.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 1.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 0.7 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 3.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 6.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 1.3 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.7 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.3 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 1.6 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 1.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 0.6 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 1.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 2.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 0.9 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 25.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.2 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.3 | 1.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 1.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 0.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 7.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 0.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.2 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 0.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.3 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 4.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 1.5 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.3 | 0.3 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) |
0.3 | 2.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 4.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 5.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 0.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 0.3 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.3 | 1.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 11.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 3.2 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 2.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 0.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.3 | 3.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 0.3 | GO:0014819 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of skeletal muscle contraction(GO:0014819) |
0.3 | 1.4 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 0.6 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.3 | 1.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 0.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 1.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 1.9 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 1.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 0.8 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 0.8 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 0.3 | GO:0048880 | sensory system development(GO:0048880) |
0.3 | 0.8 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.3 | 0.3 | GO:0072197 | negative regulation of photoreceptor cell differentiation(GO:0046533) ureter morphogenesis(GO:0072197) metanephric nephron tubule formation(GO:0072289) |
0.3 | 2.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 1.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 0.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.3 | 0.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.3 | 0.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 0.3 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.3 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 0.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 0.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.5 | GO:0050651 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.5 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.2 | 1.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 1.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 1.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 1.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.0 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.2 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 1.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.2 | 0.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 1.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 1.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 2.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 1.8 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 2.4 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 1.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 0.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 3.4 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 1.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 1.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.4 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 1.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.8 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 1.2 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 1.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.6 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 2.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 1.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.2 | 0.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 1.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 1.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.2 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.6 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 0.4 | GO:0072044 | collecting duct development(GO:0072044) |
0.2 | 3.8 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.2 | 13.2 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 1.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.2 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 0.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 1.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 0.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 0.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 1.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.2 | 0.7 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 0.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.5 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 5.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 1.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.5 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 0.2 | GO:0002434 | immune complex clearance(GO:0002434) |
0.2 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 1.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 0.8 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.2 | 0.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 1.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 1.1 | GO:0060004 | reflex(GO:0060004) |
0.2 | 0.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.2 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 1.2 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 1.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.7 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.4 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.7 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 2.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.4 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.1 | 1.7 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 1.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.4 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.3 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 3.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.6 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.5 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.5 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 1.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 1.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.7 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 1.5 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 2.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.8 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 1.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 2.1 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.3 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.5 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 1.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 1.0 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 2.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 2.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.5 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.4 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.4 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 1.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.5 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 4.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 1.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.1 | 0.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.5 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 2.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.3 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.1 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.1 | 0.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.2 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 0.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.1 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.4 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.5 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.3 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.1 | 0.1 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.1 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.2 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.2 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 1.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 2.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.1 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 1.1 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.3 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.4 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.5 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 1.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.0 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.0 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.2 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.2 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.3 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.0 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.3 | GO:0051905 | pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
0.0 | 0.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.0 | 0.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.2 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.0 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.9 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.1 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.0 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.0 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 1.4 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.2 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.0 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.4 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.2 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.0 | 0.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.0 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.0 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.0 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.0 | 0.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.0 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.0 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.0 | 0.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0032604 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
0.0 | 0.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.0 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.0 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.1 | 3.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 12.1 | GO:0043194 | axon initial segment(GO:0043194) |
1.0 | 5.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 4.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.8 | 1.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.7 | 2.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 2.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 0.7 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.6 | 6.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 17.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 3.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.6 | 1.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.6 | 2.3 | GO:0044308 | axonal spine(GO:0044308) |
0.6 | 1.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 36.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 6.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 2.4 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 13.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 4.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 1.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 2.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 1.7 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 1.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 5.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 2.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 3.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 15.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 10.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 1.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 0.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 1.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 2.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 2.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 4.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 0.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 1.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 37.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 7.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.7 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 0.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.7 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 2.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.6 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.2 | 2.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 3.3 | GO:0044298 | cell body membrane(GO:0044298) |
0.2 | 2.4 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 6.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.7 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 1.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 2.2 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.3 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 9.9 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 3.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.4 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 7.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 15.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 2.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 2.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 3.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.3 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.1 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 2.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.3 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 7.7 | GO:0098794 | postsynapse(GO:0098794) |
0.1 | 0.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 15.3 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.0 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.8 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 1.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 4.3 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 2.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 1.6 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 2.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.6 | 4.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.3 | 3.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.2 | 4.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.1 | 2.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.1 | 1.1 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 3.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.0 | 4.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.9 | 2.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.9 | 3.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.9 | 4.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.9 | 3.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.9 | 3.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.8 | 2.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.7 | 2.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 11.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.7 | 2.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 2.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.7 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 3.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.7 | 2.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 2.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.7 | 3.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.7 | 0.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.7 | 20.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 3.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.7 | 2.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.7 | 2.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 2.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 4.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 1.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 1.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.6 | 1.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 2.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 2.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 1.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 4.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 1.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 1.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 4.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.5 | 1.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 2.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.5 | 1.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 2.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.5 | 6.3 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 3.7 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.5 | 1.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.5 | 0.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.4 | 3.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 1.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 1.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 1.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 4.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 1.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 6.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 13.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 1.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 5.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 1.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 1.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 3.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 1.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 1.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.4 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 0.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.4 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 1.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.3 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.3 | 1.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 2.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.7 | GO:0005167 | neurotrophin receptor binding(GO:0005165) neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 2.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 2.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 1.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 4.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 3.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 0.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 1.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 0.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 0.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.3 | 4.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 3.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.3 | 0.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 2.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 2.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 0.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 1.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 2.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 3.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 4.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 6.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 1.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 2.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 2.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 2.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 0.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 1.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.6 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 1.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.6 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 2.8 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 5.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 2.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 4.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 1.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 1.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.6 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 7.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 2.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 5.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.5 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 0.2 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 2.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.7 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 2.6 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 2.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 1.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 2.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 1.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 3.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.8 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 5.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 3.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 1.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 4.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.3 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.1 | 1.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 1.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 2.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 3.5 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 3.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 1.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.5 | GO:0018652 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.0 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 1.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 1.0 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 1.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 2.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 1.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 1.0 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.1 | 0.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.2 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 2.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 3.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.0 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.3 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0052850 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 2.3 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 1.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 3.3 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 11.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 3.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 4.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 2.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 4.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 12.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 5.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 6.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 12.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 3.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.7 | 2.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.7 | 9.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 13.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 7.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 24.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 6.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 3.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.5 | 6.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 7.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 9.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 5.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 3.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 1.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 2.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.3 | 2.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 2.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.3 | 0.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.3 | 2.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 1.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 6.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 2.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 2.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 4.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 3.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 1.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 3.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 1.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 3.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 2.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 4.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 3.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 1.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 4.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 4.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.4 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 1.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 6.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.0 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.0 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 0.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |